Document is current

Any future updates will be listed below

A phase II trial of modified FOLFOX6 as first-line therapy for adenocarcinoma of an unknown primary site

Crossref DOI link: https://doi.org/10.1007/s00280-015-2904-7

Published Online: 2015-11-20

Published Print: 2016-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark